| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Revenues | $883.37B+43.8% | $614.38B+26.2% | $486.82B+53.9% | $316.38B+46.4% | $216.14B+103574.8% | $208.5M+0.9% | $206.5M+2.5% | $201.6M |
| Cost of sales (excluding depreciation and amortization) | $341.31B+36.4% | $250.21B+37.8% | $181.51B+30.8% | $138.78B+37.9% | $100.61B+115335.4% | $87.2M+38.0% | $63.2M-13.5% | $73.0M |
| Research and development | $51.66B+15.9% | $44.58B+30.0% | $34.29B+53.6% | $22.32B+96.3% | $11.37B+70951.8% | $16.0M-19.2% | $19.8M+28.7% | $15.4M |
| Selling, general, and administrative | $317.75B+27.3% | $249.64B+54.4% | $161.70B+30.4% | $124.04B+47.2% | $84.29B+129611.0% | $65.0M+16.4% | $55.8M+26.7% | $44.1M |
| Depreciation and amortization | $91.42B+35.0% | $67.73B+13.3% | $59.79B+4.9% | $56.97B+20.6% | $47.25B+105756.0% | $44.6M+0.1% | $44.6M+32.2% | $33.7M |
| Contingent consideration fair value adjustment | -$31.01B-4910.0% | -$619.0M-143.4% | $1.43B-62.1% | $3.76B+651.6% | $500.0M | — | $0 | — |
| Loss (gain) on disposal of assets | $382.0M+107.1% | -$5.35B | $0 | — | — | — | — | — |
| Restructuring activities | $0 | $0-100.0% | $1.13B-80.1% | $5.68B | $0 | — | — | — |
| Intangible asset impairment charge | $767.0M-89.9% | $7.60B | $0-100.0% | $112.0M-95.3% | $2.37B+532187.0% | $446K+494.7% | $75K | $0 |
| Total Operating Expenses, net | $772.27B+25.8% | $613.79B+39.5% | $439.85B+25.1% | $351.67B+37.4% | $255.93B+113904.1% | $224.5M+18.0% | $190.2M+14.4% | $166.2M |
| Operating Income | $111.09B+18922.8% | $584.0M-98.8% | $46.97B+233.1% | -$35.28B+11.3% | -$39.79B-248357.8% | -$16.0M-198.0% | $16.4M-53.8% | $35.4M |
| Unrealized gain on investment in equity securities | $2.82B-55.2% | $6.31B | $0 | $0 | — | — | — | — |
| Interest expense, net | -$20.06B-14.0% | -$17.60B+34.7% | -$26.94B+4.0% | -$28.05B-135.3% | -$11.92B-126032.0% | -$9.5M+27.1% | -$13.0M+12.1% | -$14.8M |
| Other income (expense), net | $1.93B+148.0% | -$4.03B-2436.5% | -$159.0M-123.7% | $670.0M+115.4% | -$4.34B-879049.8% | -$494K-116.7% | -$228K+58.5% | -$550K |
| Loss on extinguishment of debt | $0+100.0% | -$7.47B | $0 | $0 | — | — | — | — |
| Income (Loss) Before Expense (Benefit) for Income Taxes | $95.79B+531.3% | -$22.21B-211.8% | $19.87B+131.7% | -$62.66B-11.8% | -$56.06B-215823.3% | -$26.0M-922.4% | $3.2M-84.3% | $20.1M |
| Income tax expense (benefit) | $17.45B+573.0% | -$3.69B-437.6% | $1.09B+107.4% | -$14.77B-9.8% | -$13.46B-394212.5% | $3.4M+16.2% | $2.9M+164.5% | -$4.6M |
| Net Income (Loss) | $78.34B+522.9% | -$18.52B-198.6% | $18.78B+139.2% | -$47.90B-12.4% | -$42.60B-188843.6% | -$22.5M-470.0% | $6.1M-60.7% | $15.5M |
| Dividends on Series A Convertible Preferred Stock | -$1.16B+28.8% | -$1.63B+0.0% | -$1.63B+0.0% | -$1.63B-755.3% | -$190.0M | — | — | — |
| Net Income (Loss) Available to Common Shareholders | $77.18B+483.1% | -$20.15B-217.4% | $17.15B+134.6% | -$49.52B-15.7% | -$42.79B-189686.2% | -$22.5M-470.0% | $6.1M | — |
| Basic Income (Loss) Per Share (in dollars per share) | $3500.00+436.5% | -$1040.00-220.9% | $860.00+128.2% | -$3050.00+10.3% | -$3400.00-80.9% | -$1880.00-468.6% | $510.00-61.1% | $1310.00 |
| Diluted Income (Loss) Per Share (in dollars per share) | $3320.00+419.2% | -$1040.00-222.4% | $850.00+127.9% | -$3050.00+10.3% | -$3400.00-80.9% | -$1880.00-476.0% | $500.00-61.5% | $1300.00 |
| Basic Weighted-Average Shares Outstanding (in shares) | 20.1M+3.8% | 19.3M+7.3% | 18.0M+10.7% | 16.3M+29.1% | 12.6M+5.3% | 12.0M+1.0% | 11.8M+1.4% | 11.7M |
| Diluted Weighted-Average Shares Outstanding (in shares) | 21.2M+9.9% | 19.3M+6.2% | 18.2M+11.9% | 16.3M+29.1% | 12.6M+5.3% | 12.0M-0.6% | 12.0M+2.3% | 11.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.